A new trading day began on Friday, with Pulmonx Corp (NASDAQ: LUNG) stock price down -5.51% from the previous day of trading, before settling in for the closing price of $8.35. LUNG’s price has ranged from $7.75 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 30.02%. Meanwhile, its annual earnings per share averaged -15.97%. With a float of $34.95 million, this company’s outstanding shares have now reached $38.52 million.
Considering the fact that the conglomerate employs 279 people, you should pay attention to its efficiency factor.
Pulmonx Corp (LUNG) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pulmonx Corp is 9.31%, while institutional ownership is 87.88%. The most recent insider transaction that took place on Mar 22 ’24, was worth 11,082. In this transaction CHIEF COMMERCIAL OFFICER of this company sold 1,184 shares at a rate of $9.36, taking the stock ownership to the 307,868 shares. Before that another transaction happened on Mar 01 ’24, when Company’s PRESIDENT AND CEO sold 6,954 for $9.06, making the entire transaction worth $63,003. This insider now owns 1,116,758 shares in total.
Pulmonx Corp (LUNG) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 156.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.60% during the next five years compared to -25.16% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Here are Pulmonx Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.60, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Compared to the last year’s volume of 0.52 million, its volume of 0.73 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.93%. Additionally, its Average True Range was 0.45.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 2.39%, which indicates a significant decrease from 9.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.38% in the past 14 days, which was higher than the 56.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.56, while its 200-day Moving Average is $11.12. Nevertheless, the first resistance level for the watch stands at $8.19 in the near term. At $8.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.72. If the price goes on to break the first support level at $7.66, it is likely to go to the next support level at $7.42. Should the price break the second support level, the third support level stands at $7.13.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
With a market capitalization of 304.08 million, the company has a total of 38,537K Shares Outstanding. Currently, annual sales are 68,680 K while annual income is -60,840 K. The company’s previous quarter sales were 19,280 K while its latest quarter income was -13,890 K.
